People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Protaryx Medical Inc. | — | Healthtech | Series A | $8.1M | $183.1M | 2020 |
| Harpoon Medical, Inc. | — | Biotechnology | Seed | $7.8M | $173.2M | 2014 |
James Gammie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Gammie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Duke Rohlen | 1 | 10 |
| Aftab Kherani | 1 | 9 |
| James Cox | 1 | 6 |
| Mark Collins | 1 | 5 |
| Kyparissia Sirinakis | 1 | 4 |
| William Niland | 1 | 4 |
| Peter Boyd | 1 | 2 |
| Terri Burke | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.